Trial intelligence / Profile preview

Low Dose Prednisolone for Knee Osteoarthritis

NCT01619163Phase 4Completed

Sponsor
Alexandria University
Start
Nov 2011
Primary completion
Dec 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Pain reduction at 6 weeks. Started Nov 2011; status: completed.

02

Drugs

prednisolone
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01619163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01619163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call